Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

Equities researchers at StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock.

Concord Medical Services Stock Performance

Concord Medical Services stock opened at $5.00 on Friday. Concord Medical Services has a 52 week low of $3.82 and a 52 week high of $26.70. The company has a current ratio of 0.47, a quick ratio of 0.46 and a debt-to-equity ratio of 1.15. The stock has a 50-day simple moving average of $6.58 and a 200 day simple moving average of $7.12.

Concord Medical Services Company Profile

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.